Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S Azman

Showing results (151-160 of 204) with videos related to

Pageof 21
Sort By:
The Lancet. Global Health|October 18, 2024
Safety of hepatitis E vaccine in pregnancy: an emulated target trial following a mass reactive vaccination campaign in Bentiu internally displaced persons camp, South SudanRobin C Nesbitt, Andrew S Azman, Vincent Kinya Asilaza, et al.
BMJ Public Health|February 28, 2025
Challenges with achieving and maintaining oral cholera vaccine coverage: insights from serial cross-sectional representative surveys in a cholera-endemic community in the Democratic Republic of the CongoAybüke Koyuncu, Patrick Musole Bugeme, Juan Dent, et al.
Tropical Medicine & International Health : TM & IH|June 1, 2018
Evaluation of the SD bioline cholera rapid diagnostic test during the 2016 cholera outbreak in Lusaka, ZambiaJohn Mwaba, Eva Ferreras, Elizabeth Chizema-Kawesa, et al.
Lancet (London, England)|March 6, 2018
Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scalesJustin Lessler, Sean M Moore, Francisco J Luquero, et al.
Scientific Reports|October 25, 2016
Immune Responses to an Oral Cholera Vaccine in Internally Displaced Persons in South SudanAnita S Iyer, Malika Bouhenia, John Rumunu, et al.
The New England Journal of Medicine|January 7, 2016
Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus DiseaseEtienne Gignoux, Andrew S Azman, Martin de Smet, et al.
Scandinavian Journal of Public Health|October 19, 2021
Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based studyAude Richard, Ania Wisniak, Javier Perez-Saez, et al.
Nature Communications|June 9, 2021
Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, SwitzerlandSilvia Stringhini, María-Eugenia Zaballa, Nick Pullen, et al.
The Journal of Infectious Diseases|June 5, 2026
Estimating the Transmission Potential of Symptomatic and Asymptomatic Cholera Cases from Household Microbiological and Clinical DataClaire P Smith, Justin Lessler, Sonia T Hegde, et al.
Medrxiv : the Preprint Server for Health Sciences|January 16, 2026
Estimating the Transmission Potential of Symptomatic and Asymptomatic Cholera Cases from Household Microbiological and Clinical DataClaire P Smith, Justin Lessler, Sonia T Hegde, et al.
Pageof 21

Showing results (151-160 of 204) with videos related to

Sort By:
Pageof 21
The Lancet. Global Health|October 18, 2024
Safety of hepatitis E vaccine in pregnancy: an emulated target trial following a mass reactive vaccination campaign in Bentiu internally displaced persons camp, South SudanRobin C Nesbitt, Andrew S Azman, Vincent Kinya Asilaza, et al.
BMJ Public Health|February 28, 2025
Challenges with achieving and maintaining oral cholera vaccine coverage: insights from serial cross-sectional representative surveys in a cholera-endemic community in the Democratic Republic of the CongoAybüke Koyuncu, Patrick Musole Bugeme, Juan Dent, et al.
Tropical Medicine & International Health : TM & IH|June 1, 2018
Evaluation of the SD bioline cholera rapid diagnostic test during the 2016 cholera outbreak in Lusaka, ZambiaJohn Mwaba, Eva Ferreras, Elizabeth Chizema-Kawesa, et al.
Lancet (London, England)|March 6, 2018
Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scalesJustin Lessler, Sean M Moore, Francisco J Luquero, et al.
Scientific Reports|October 25, 2016
Immune Responses to an Oral Cholera Vaccine in Internally Displaced Persons in South SudanAnita S Iyer, Malika Bouhenia, John Rumunu, et al.
The New England Journal of Medicine|January 7, 2016
Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus DiseaseEtienne Gignoux, Andrew S Azman, Martin de Smet, et al.
Scandinavian Journal of Public Health|October 19, 2021
Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based studyAude Richard, Ania Wisniak, Javier Perez-Saez, et al.
Nature Communications|June 9, 2021
Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, SwitzerlandSilvia Stringhini, María-Eugenia Zaballa, Nick Pullen, et al.
The Journal of Infectious Diseases|June 5, 2026
Estimating the Transmission Potential of Symptomatic and Asymptomatic Cholera Cases from Household Microbiological and Clinical DataClaire P Smith, Justin Lessler, Sonia T Hegde, et al.
Medrxiv : the Preprint Server for Health Sciences|January 16, 2026
Estimating the Transmission Potential of Symptomatic and Asymptomatic Cholera Cases from Household Microbiological and Clinical DataClaire P Smith, Justin Lessler, Sonia T Hegde, et al.
Pageof 21